Original Investigation

Intermittent Theta-Burst Stimulation for Depressive Symptoms in Parkinson Disease

JAMA Network Open 10.1001/jamanetworkopen.2026.13580

May 20, 2026 at 11:00 AM EDT

Read the full article

Can the ultra-brief intermittent theta-burst stimulation (iTBS) protocol provide a time-efficient and effective alternative to standard high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) for treating depressive symptoms in Parkinson disease (PD)?In this randomized clinical trial including 54 patients with PD and depressive symptoms, both iTBS and HF-rTMS produced significant and comparable reductions in depressive symptoms compared with sham stimulation.This study suggests that the ultra-brief iTBS protocol achieved antidepressant efficacy comparable with that of standard HF-rTMS in PD while reducing treatment time, offering a pragmatic and patient-centered advancement for clinical management.

Corresponding Authors: Yu Zhang, PhD (zhangyu06@xinhuamed.com.cn), and Zhenguo Liu, PhD (liuzhenguo@xinhuamed.com.cn), Department of Neurology, Xinhua Hospital affiliated with Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Rd, Yangpu District, Shanghai, China, 200092.

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks